Release of tissue-specific proteins into coronary perfusate as a model for biomarker discovery in myocardial ischemia/reperfusion injury

Journal of Proteome Research

Volumn 11, Issue 4, 2012, Pages 2114-2126

  Cordwell, Stuart J ^a   Edwards, Alistair V G ^a   Liddy, Kiersten A ^a   Moshkanbaryans, Lia ^a   Solis, Nestor ^a   Parker, Benjamin L ^a   Yong, Andy S C ^b   Wong, Clement ^b   Kritharides, Leonard ^b   Hambly, Brett D ^a   White, Melanie Y ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b Department of Geriatric Medicine   (Australia)

Author keywords

biomarkers; cysteine and glycine rich protein 3 (Csrp3); ischemia reperfusion; Langendorff perfusion; myosin binding protein C

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; MYOGLOBIN; PROTEIN; PROTEIN CYSTEINE AND GLYCINE RICH PROTEIN 3; TROPONIN I; TROPONIN T; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CLINICAL ARTICLE; EX VIVO STUDY; GEL ELECTROPHORESIS; HEART MUSCLE ISCHEMIA; HUMAN; ISOLATED HEART; LIQUID CHROMATOGRAPHY; MALE; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; RABBIT; REPERFUSION INJURY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TANDEM MASS SPECTROMETRY; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; BIOLOGICAL MARKERS; BLOTTING, WESTERN; CHROMATOGRAPHY, LIQUID; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; LIM DOMAIN PROTEINS; MALE; MOLECULAR SEQUENCE DATA; MUSCLE PROTEINS; MYOCARDIAL REPERFUSION INJURY; NECROSIS; PROTEOME; PROTEOMICS; RABBITS; REPRODUCIBILITY OF RESULTS; TANDEM MASS SPECTROMETRY; VENTRICULAR FUNCTION, LEFT;

ANIMALIA; ORYCTOLAGUS CUNICULUS;

EID: 84859600856     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr2006928     Document Type: Article

References (56)

1. Roger, V. L.; Go, A. S.; Lloyd-Jones, D. M.; Adams, R. J.; Berry, J. D.; Brown, T. M.; Carnethon, M. R.; Dai, S.; de Simone, G.; Ford, E. S.; Fox, C. S.; Fullerton, H. J.; Gillespie, C.; Greenlund, K. J.; Hailpern, S. M.; Heit, J. A.; Ho, P. M.; Howard, V. J.; Kissela, B. M.; Kittner, S. J.; Lackland, D. T.; Lichtman, J. H.; Lisabeth, L. D.; Makuc, D. M.; Marcus, G. M.; Marelli, A.; Matchar, D. B.; McDermott, M. M.; Meigs, J. B.; Moy, C. S.; Mozaffarian, D.; Mussolino, M. E.; Nichol, G.; Paynter, N. P.; Rosamond, W. D.; Sorlie, P. D.; Stafford, R. S.; Turan, T. N.; Turner, M. B.; Wong, N. D.; Wylie-Rosett, J. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2011 update: a report from the American Heart Association Circulation 2011, 123 (4) e18-e209
2. Boland, L. L.; Folsom, A. R.; Sorlie, P. D.; Taylor, H. A.; Rosamond, W. D.; Chambless, L. E.; Cooper, L. S. Occurrence of unrecognized myocardial infarction in subjects aged 45 to 65 years (the ARIC study) Am. J. Cardiol. 2002, 90 (9) 927-931
3. Anderson, N. L.; Anderson, N. G. The human plasma proteome: history, character, and diagnostic prospects Mol. Cell. Proteomics 2002, 1 (11) 845-867
4. Hu, S.; Loo, J. A.; Wong, D. T. Human body fluid proteome analysis Proteomics 2006, 6 (23) 6326-6353
5. Vasan, R. S. Biomarkers of cardiovascular disease: molecular basis and practical considerations Circulation 2006, 113 (19) 2335-2362
6. Anderson, N. L. The clinical plasma proteome: a survey of clinical assays for proteins in plasma and serum Clin. Chem. 2010, 56 (2) 177-185
7. Siriwardena, M.; Kleffmann, T.; Ruygrok, P.; Cameron, V. A.; Yandle, T. G.; Nicholls, M. G.; Richards, A. M.; Pemberton, C. J. B-type natriuretic peptide signal peptide circulates in human blood: evaluation as a potential biomarker of cardiac ischemia Circulation 2010, 122 (3) 255-264
8. French, J. K.; White, H. D. Clinical implications of the new definition of myocardial infarction Heart 2004, 90 (1) 99-106
9. Lin, J. C.; Apple, F. S.; Murakami, M. M.; Luepker, R. V. Rates of positive cardiac troponin I and creatine kinase MB mass among patients hospitalized for suspected acute coronary syndromes Clin. Chem. 2004, 50 (2) 333-338
10. Chan, D.; Ng, L. L. Biomarkers in acute myocardial infarction BMC Med. 2010, 8, 34
11. Ohman, E. M.; Casey, C.; Bengtson, J. R.; Pryor, D.; Tormey, W.; Horgan, J. H. Early detection of acute myocardial infarction: additional diagnostic information from serum concentrations of myoglobin in patients without ST elevation Br. Heart J. 1990, 63 (6) 335-338
12. Parikh, S. V.; de Lemos, J. A. Biomarkers in cardiovascular disease: integrating pathophysiology into clinical practice Am. J. Med. Sci. 2006, 332 (4) 186-197
13. Stork, T. V.; Wu, A. H.; Müller-Bardorff, M.; Gareis, R.; Müller, R.; Hombach, V.; Katus, H.; Möckel, M. North Wurttemberg Infarction (NOWIS) Group. Diagnostic and prognostic role of myoglobin in patients with suspected acute coronary syndrome. North-Wurttemberg Infarction Study (NOWIS) Group Am. J. Cardiol. 2000, 86 (12) 1371-1374
14. Christenson, R. H.; Azzazy, H,M. Biomarkers of myocardial necrosis: past, present and future. In Cardiovascular biomarkers: pathophysiology and disease management; Morrow, D., Ed.; Humana Press: Totowa, N.J., 2006; pp 1-24.
15. Saenger, A. K.; Jaffe, A. S. Requiem for a heavyweight: the demise of creatine kinase-MB Circulation 2008, 118 (21) 2200-2206
16. Tsung, J. S.; Tsung, S. S. Creatine kinase isoenzymes in extracts of various human skeletal muscles Clin. Chem. 1986, 32 (8) 1568-1570
17. Saenger, A. K.; Jaffe, A. S. The use of biomarkers for the evaluation and treatment of patients with acute coronary syndromes Med. Clin. North Am. 2007, 91 (4) 657-681
18. Wattanapermpool, J.; Guo, X.; Solaro, R. J. The unique amino-terminal peptide of cardiac troponin I regulates myofibrillar activity only when it is phosphorylated J. Mol. Cell. Cardiol. 1995, 27 (7) 1383-1391
19. McDonough, J. L.; Labugger, R.; Pickett, W.; Tse, M. Y.; MacKenzie, S.; Pang, S. C.; Atar, D.; Ropchan, G.; Van Eyk, J. E. Cardiac troponin I is modified in the myocardium of bypass patients Circulation 2001, 103 (1) 58-64
20. White, M. Y.; Cordwell, S. J.; McCarron, H. C.; Tchen, A. S.; Hambly, B. D.; Jeremy, R. W. Modifications of myosin-regulatory light chain correlate with function of stunned myocardium J. Mol. Cell. Cardiol. 2003, 35 (7) 833-840
21. Thygesen, K.; Alpert, J. S.; White, H. D. Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction. Universal definition of myocardial infarction J. Am. Coll. Cardiol. 2007, 50 (22) 2173-2195
22. Keller, T.; Zeller, T.; Peetz, D.; Tzikas, S.; Roth, A.; Czyz, E.; Bickel, C.; Baldus, S.; Warnholtz, A.; Fröhlich, M.; Sinning, C. R.; Eleftheriadis, M. S.; Wild, P. S.; Schnabel, R. B.; Lubos, E.; Jachmann, N.; Genth-Zotz, S.; Post, F.; Nicaud, V.; Tiret, L.; Lackner, K. J.; Münzel, T. F.; Blankenberg, S. Sensitive troponin I assay in early diagnosis of acute myocardial infarction N. Engl. J. Med. 2009, 361 (9) 868-877
23. Reichlin, T.; Hochholzer, W.; Bassetti, S.; Steuer, S.; Stelzig, C.; Hartwiger, S.; Biedert, S.; Schaub, N.; Buerge, C.; Potocki, M.; Noveanu, M.; Breidthardt, T.; Twerenbold, R.; Winkler, K.; Bingisser, R.; Mueller, C. Early diagnosis of myocardial infarction with sensitive cardiac troponin assays N. Engl. J. Med. 2009, 361 (9) 858-867
24. Apple, F. S.; Wu, A. H.; Mair, J.; Ravkilde, J.; Panteghini, M.; Tate, J.; Pagani, F.; Christenson, R. H.; Mockel, M.; Danne, O.; Jaffe, A. S. Committee on Standardization of Markers of Cardiac Damage of the IFCC. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome Clin. Chem. 2005, 51 (5) 810-824
25. Bolli, R. Mechanism of myocardial "stunning" Circulation 1990, 82 (3) 723-738
26. Bolli, R.; Marban, E. Molecular and cellular mechanisms of myocardial stunning Physiol. Rev. 1999, 79 (2) 609-634
27. Edwards, A. V. G.; White, M. Y.; Cordwell, S. J. The role of proteomics in clinical cardiovascular biomarker discovery Mol. Cell. Proteomics 2008, 7 (10) 1824-1837
28. Mayr, M.; Zhang, J.; Greene, A. S.; Gutterman, D.; Perloff, J.; Ping, P. Proteomics-based development of biomarkers in cardiovascular disease: mechanistic, clinical, and therapeutic insights Mol. Cell. Proteomics 2006, 5 (10) 1853-1864
29. Apweiler, R.; Aslanidis, C.; Deufel, T.; Gerstner, A.; Hansen, J.; Hochstrasser, D.; Kellner, R.; Kubicek, M.; Lottspeich, F.; Maser, E.; Mewes, H. W.; Meyer, H. E.; Müllner, S.; Mutter, W.; Neumaier, M.; Nollau, P.; Nothwang, H. G.; Ponten, F.; Radbruch, A.; Reinert, K.; Rothe, G.; Stockinger, H.; Tarnok, A.; Taussig, M. J.; Thiel, A.; Thiery, J.; Ueffing, M.; Valet, G.; Vandekerckhove, J.; Verhuven, W.; Wagener, C.; Wagner, O.; Schmitz, G. Approaching clinical proteomics: current state and future fields of application in fluid proteomics Clin. Chem. Lab. Med. 2009, 47 (6) 724-744
30. Huttenhain, R.; Malmstrom, J.; Picotti, P.; Aebersold, R. Perspectives of targeted mass spectrometry for protein biomarker verification Curr. Opin. Chem. Biol. 2009, 13 (5-6) 518-525
31. Schoenhoff, F. S.; Fu, Q.; Van Eyk, J. E. Cardiovascular proteomics: implications for clinical applications Clin. Lab. Med. 2009, 29 (1) 87-99
32. Gundry, R. L.; Fu, Q.; Jelinek, C. A.; Van Eyk, J. E.; Cotter, R. J. Investigation of an albumin-enriched fraction of human serum and its albuminome Proteomics Clin. Appl. 2007, 1, 73-88
33. Jacquet, S.; Yin, X.; Sicard, P.; Clark, J.; Kanaganayagam, G. S.; Mayr, M.; Marber, M. S. Identification of cardiac myosin-binding protein C as a candidate biomarker of myocardial infarction by proteomics analysis Mol. Cell. Proteomics 2009, 8 (12) 2687-2699
34. White, M. Y.; Cordwell, S. J.; McCarron, H. C.; Prasan, A. M.; Craft, G.; Hambly, B. D.; Jeremy, R. W. Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems Proteomics 2005, 5 (5) 1395-1410
35. White, M. Y.; Tchen, A. S.; McCarron, H. C.; Hambly, B. D.; Jeremy, R. W.; Cordwell, S. J. Proteomics of ischemia and reperfusion injuries in rabbit myocardium with and without intervention by an oxygen-free radical scavenger Proteomics 2006, 6 (23) 6221-6233
36. Prasan, A. M.; McCarron, H. C.; Hambly, B. D.; Fermanis, G. G.; Sullivan, D. R.; Jeremy, R. W. Effect of treatment on ventricular function and troponin I proteolysis in reperfused myocardium J. Mol. Cell. Cardiol. 2002, 34 (4) 401-411
37. Jiang, L.; He, L.; Fountoulakis, M. Comparison of protein precipitation methods for sample preparation prior to proteomic analysis J. Chromatogr., A 2004, 1023 (2) 317-320
38. Cordwell, S. J. Acquisition and archiving of information for bacterial proteomics: from sample preparation to database Methods Enzymol. 2002, 358, 207-227
39. Altschul, S. F.; Lipman, D. J. Protein database searches for multiple alignments Proc. Natl. Acad. Sci. U.S.A. 1990, 87 (14) 5509-5513
40. Kussmann, M.; Nordhoff, E.; Nielsen, H. R.; Haebel, S.; Larsen, M. R.; Jacobsen, L.; Gobom, J.; Mirgorodskaya, E.; Kroll-Kristensen, A.; Roepstorff, P. Matrix-assisted laser desorption ionization mass spectrometry sample preparation techniques designed for various peptide and protein analytes J. Mass Spectrom. 1997, 32 (6) 593-601
41. Liu, H.; Sadygov, R. G.; Yates, J. R., 3rd. A model for random sampling and estimation of relative protein abundance in shotgun proteomics Anal. Chem. 2004, 76 (14) 4193-4201
42. Pang, J. X.; Ginanni, N.; Dongre, A. R.; Hefta, S. A.; Opitek, G. J. Biomarker discovery in urine by proteomics J. Proteome Res. 2002, 1 (2) 161-169
43. Mateos-Cáceres, P. J.; García-Méndez, A.; López Farré, A.; Macaya, C.; Núñez, A.; Gómez, J.; Alonso-Orgaz, S.; Carrasco, C.; Burgos, M. E.; de Andrés, R.; Granizo, J. J.; Farré, J.; Rico, L. A. Proteomic analysis of plasma from patients during an acute coronary syndrome J. Am. Coll. Cardiol. 2004, 44 (8) 1578-1583
44. ODonoghue, M.; de Lemos, J. A.; Morrow, D. A.; Murphy, S. A.; Buros, J. L.; Cannon, C. P.; Sabatine, M. S. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes Circulation 2006, 114 (6) 550-557
45. Ghani, F.; Wu, A. H.; Graff, L.; Petry, C.; Armstrong, G.; Prigent, F.; Brown, M. Role of heart-type fatty acid-binding protein in early detection of acute myocardial infarction Clin. Chem. 2000, 46 (5) 718-719
46. Ichijo, H.; Nishida, E.; Irie, K.; ten Dijke, P.; Saitoh, M.; Moriguchi, T.; Takagi, M.; Matsumoto, K.; Miyazono, K.; Gotoh, Y. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways Science 1997, 275 (5296) 90-94
47. Levin, E. R.; Gardner, D. G.; Samson, W. K. Natriuretic peptides N. Engl. J. Med. 1998, 339 (5) 321-328
48. Squire, I. B.; OBrien, R. J.; Demme, B.; Davies, J. E.; Ng, L. L. N -terminal pro-atrial natriuretic peptide (N-ANP) and N -terminal pro-B-type natriuretic peptide (N-BNP) in the prediction of death and heart failure in unselected patients following acute myocardial infarction Clin. Sci. 2004, 107 (3) 309-316
49. Khan, S. Q.; Dhillon, O.; Kelly, D.; Squire, I. B.; Struck, J.; Quinn, P.; Morgenthaler, N. G.; Bergmann, A.; Davies, J. E.; Ng, L. L. Plasma N -terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study J. Am. Coll. Cardiol. 2008, 51 (19) 1857-1864
50. Khan, S. Q.; Quinn, P.; Davies, J. E.; Ng, L. L. N -terminal pro-B-type natriuretic peptide is better than TIMI risk score at predicting death after acute myocardial infarction Heart 2008, 94 (1) 40-43
51. Fung, Y. W.; Wang, R.; Liew, C. Characterization of a human cardiac gene which encodes for a LIM domain protein and is developmentally expressed in myocardial development J. Mol. Cell. Cardiol. 1996, 28, 1203-1210
52. Su, A. I.; Wiltshire, T.; Batalov, S.; Lapp, H.; Ching, K. A.; Block, D.; Zhang, J.; Soden, R.; Hayakawa, M.; Kreiman, G.; Cooke, M. P.; Walker, J. R.; Hogenesch, J. B. A gene atlas of the mouse and human protein-encoding transcriptomes Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (16) 6062-6067
53. Geier, C.; Gehmlich, K.; Ehler, E.; Hassfeld, S.; Perrot, A.; Hayess, K.; Cardim, N.; Wenzel, K.; Erdmann, B.; Krackhardt, F.; Posch, M. G.; Osterziel, K. J.; Bublak, A.; Nägele, H.; Scheffold, T.; Dietz, R.; Chien, K. R.; Spuler, S.; Fürst, D. O.; Nürnberg, P.; Ozcelik, C. Beyond the sarcomere: CSRP3 mutations cause hypertrophic cardiomyopathy Hum. Mol. Genet. 2008, 17 (18) 2753-2765
54. Hershberger, R. E.; Parks, S. B.; Kushner, J. D.; Li, D.; Ludwigsen, S.; Jakobs, P.; Nauman, D.; Burgess, D.; Partain, J.; Litt, M. Coding sequence mutations identified in MYH7, TNNT2, SCN5A, CSRP3, LBD3, and TCAP from 313 patients with familial or idiopathic dilated cardiomyopathy Clin. Transl. Sci. 2008, 1 (1) 21-26
55. Knöll, R.; Kostin, S.; Klede, S.; Savvatis, K.; Klinge, L.; Stehle, I.; Gunkel, S.; Kötter, S.; Babicz, K.; Sohns, M.; Miocic, S.; Didié, M.; Knöll, G.; Zimmermann, W. H.; Thelen, P.; Bickeböller, H.; Maier, L. S.; Schaper, W.; Schaper, J.; Kraft, T.; Tschöpe, C.; Linke, W. A.; Chien, K. R. A common MLP (muscle LIM protein) variant is associated with cardiomyopathy Circ. Res. 2010, 106 (4) 695-704
56. Marques, F. Z.; Campain, A. E.; Yang, Y. H.; Morris, B. J. Meta-analysis of genome-wide gene expression differences in onset and maintenance phases of genetic hypertension Hypertension 2010, 56 (2) 319-324